Reynolds American Inc (RAI) 45.52 $RAI Big-Cap Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Reynolds American Inc (RAI) 45.52 $RAI

Big-Cap Stocks Show Slow-And-Steady Can Win The Race
at Investor's Business Daily - Wed Nov 11, 5:10PM CST
Big-cap stocks are sometimes like the tortoise in the Aesop's fable "The Tortoise and the Hare," lumbering along while rabbit-like growth stocks speed ahead. But sometimes, as in the fable, slow-and-steady really does win the race. Just look at the...
RAI: 45.52 (+0.11), SBUX: 59.74 (-1.33), ORLY: 259.83 (-7.07), OHI: 32.36 (+0.04), DTE: 79.53 (-0.50)

5 Toxic Stocks to Sell Now
at The Street - Fri Nov 06, 8:51AM CST
Here's a technical look at five stocks you need to unload from your portfolio in November.
RAI: 45.52 (+0.11), NFLX: 103.65 (-5.27), NOV: 37.33 (-0.12), AMZN: 642.35 (-23.25), KRFT: 88.19 (-0.11), RDY: 52.53 (+2.67), RGR: 48.95 (-0.59), LUX: 66.39 (-1.08), APD: 137.38 (+2.08)

Advisory: RAI recommends shareholders reject TRC Capital 'mini-tender' offer
PR Newswire - Thu Nov 05, 6:30AM CST
Reynolds American Inc. (NYSE: RAI) has announced the following: "RAI recommends shareholders reject 'mini-tender' offer by TRC Capital Corporation."
RAI: 45.52 (+0.11)

5 Things Reynolds American Executives Need You to Know
Dan Caplinger, The Motley Fool - Motley Fool - Tue Nov 03, 6:00PM CST
Reynolds CEO Susan Cameron. Image source: Reynolds American. Tobacco giant Reynolds American released its third-quarter financial report in late October, and the company posted solid results following the conclusion of its long-awaited...
RAI: 45.52 (+0.11), MO: 56.28 (-0.48)

Reynolds American Set to Possibly Rebound After Yesterday's Selloff of 4.01%
Comtex SmarTrend(R) - Tue Nov 03, 4:04PM CST
Reynolds American (NYSE:RAI) traded in a range yesterday that spanned from a low of $45.62 to a high of $47.50. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $47.61 on volume of 9.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
RAI: 45.52 (+0.11)

Reynolds American Falls 4.01% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Nov 03, 4:03PM CST
Reynolds American (NYSE:RAI) traded in a range yesterday that spanned from a low of $45.62 to a high of $47.50. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $47.61 on volume of 9.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
RAI: 45.52 (+0.11)

Kellogg EPS Disappoints; Reynolds, Altria Downgraded
at Investor's Business Daily - Tue Nov 03, 3:50PM CST
Kellogg (K) led a passel of dividend leaders lower Tuesday after it issued a Q3 report that disappointed investors. The stock gapped lower and was trading below a 69.95 buy point from a cup-with-handle base. The stock finished around the middle of...
RAI: 45.52 (+0.11), MO: 56.28 (-0.48), K: 66.09 (-0.21)

Stocks Battle Onto Mixed Turf; Early Risers: Discovery, Sykes
at Investor's Business Daily - Tue Nov 03, 9:41AM CST
Stocks pulled up from narrow, opening losses into mixed action Tuesday, as earnings results powered the bulk of early trade. The Dow Jones industrial average wrestled to a 0.1% gain. The Nasdaq and S&P 500 each hung 0.2% into the red. Volume jumped...
RAI: 45.52 (+0.11), MLM: 153.43 (+1.93), AFSI: 58.64 (+0.39), DISCA: 29.98 (-0.18), FCAU: 13.52 (-0.04), DY: 81.82 (-1.10), SYKE: 30.08 (-0.30), ADM: 37.76 (-0.75), GM: 34.31 (-0.78), CVX: 88.68 (-1.18)

Reynolds American (RAI) Stock Downgraded at RBC
at The Street - Tue Nov 03, 9:04AM CST
Reynolds American (RAI) stock was downgraded to ‘outperform’ from ‘top pick’ at RBC Capital Markets.
RAI: 45.52 (+0.11)

Analysts Actions -- AIG, Altria, Nvidia, Visa
at The Street - Tue Nov 03, 7:42AM CST
Here are Tuesday's top research calls, including ratings and earnings changes at AIG, Altria, Nvidia and Visa.
MBI: 6.90 (+0.25), RAI: 45.52 (+0.11), VRX: 75.41 (+1.64), V: 78.11 (-0.20), JAH: 45.62 (-1.77), MO: 56.28 (-0.48), AIG: 59.31 (-0.07), NVDA: 29.80 (-0.60)

Downgrade Alert for Reynolds American (RAI)
Comtex SmarTrend(R) - Tue Nov 03, 7:20AM CST
Reynolds American (NYSE:RAI) was downgraded from Top Pick to Outperform at RBC Capital today. The stock closed yesterday at $47.83 on volume of 5.9 million shares, below average daily volume of 7.0 million. Reynolds American share prices have moved between a 52-week high of $49.56 and a 52-week low of $31.34 and closed yesterday at 53% above that low price at $47.90 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.8% while the 200-day MA has risen 0.6%.
RAI: 45.52 (+0.11)

Better Buy Now: Altria Group Inc or Reynolds American Inc?
Leo Sun, The Motley Fool - Motley Fool - Mon Nov 02, 5:00PM CST
Altria and Reynolds American , the two biggest domestic tobacco companies in the U.S., have been sound investments recently thanks to their protection from currency fluctuations, lower gas prices boosting...
RAI: 45.52 (+0.11), BUD: 120.13 (-1.10), MO: 56.28 (-0.48)

Watch for Shares of Reynolds American (RAI) to Approach Support at $47.85
Comtex SmarTrend(R) - Mon Nov 02, 10:21AM CST
Reynolds American (NYSE:RAI) has opened bearishly below the pivot of $48.54 today and has reached the first level of support at $48.09. Analysts will be watching for a cross of the next downside pivot targets of $47.85 and $47.16.
RAI: 45.52 (+0.11)

Uptrend Call Working As Reynolds American Stock Rises 10.4% (RAI)
Comtex SmarTrend(R) - Mon Nov 02, 10:10AM CST
SmarTrend identified an Uptrend for Reynolds American (NYSE:RAI) on September 29th, 2015 at $43.69. In approximately 1 month, Reynolds American has returned 10.41% as of today's recent price of $48.24.
RAI: 45.52 (+0.11)

Reynolds American Rides Lorillard to Big Gains
Dan Caplinger, The Motley Fool - Motley Fool - Fri Oct 30, 5:15PM CDT
Image source: Reynolds American. Big acquisitions have big impacts, and the deal by which Reynolds American bought out rival Lorillard created a behemoth that now poses an even bigger threat to tobacco-industry leader Altria Group than it did...
RAI: 45.52 (+0.11), MO: 56.28 (-0.48)

Advisory: RAI to webcast Investor Day presentations
PR Newswire - Fri Oct 30, 7:41AM CDT
Reynolds American Inc. (NYSE: RAI) has announced the following: "RAI to webcast Investor Day presentations in London and New York."
RAI: 45.52 (+0.11)

REYNOLDS AMERICAN INC (RAI) Earnings Report: Q3 Conference Call Transcript
at The Street - Tue Oct 27, 4:18PM CDT
The following REYNOLDS AMERICAN INC (RAI) conference call took place on October 27, 2015, 09:00 AM ET. This is a transcript of that earnings call:
RAI: 45.52 (+0.11)

Reynolds American's RJR Market Share Dips In Q3
at Investor's Business Daily - Tue Oct 27, 3:31PM CDT
Reynolds American's (RAI) recent purchase of the maker of Newport cigarettes -- and increased prices for tobacco-related products -- helped fuel its Q3 revenue, though RJR market share dipped. Excluding items, the parent company of R.J. Reynolds...
RAI: 45.52 (+0.11), MO: 56.28 (-0.48)

Stocks End Slightly Lower; Integrated Device Fades
at Investor's Business Daily - Tue Oct 27, 3:30PM CDT
Stocks ended modestly lower Tuesday amid mixed economic data, more earnings reports and the start of a two-day Fed meeting. The S&P 500 and the Dow Jones industrial average lost 0.3% and 0.2%, respectively. Meanwhile, the Nasdaq eased 0.1%. According...
RAI: 45.52 (+0.11), WBA: 79.17 (-1.23), CALM: 54.17 (-1.07), IDTI: 25.53 (-0.06), RAD: 7.60 (-0.08)

Walgreens Targets Rival Rite Aid; Apple Reverses Ahead Of Earnings
at Investor's Business Daily - Tue Oct 27, 12:26PM CDT
Stocks gave up further ground in early afternoon trading as earnings continued to take center stage. The S&P 500 fell 0.5%, the Nasdaq slid 0.4% and the Dow Jones industrial average gave up 0.3%. Volume was tracking higher across the board vs. the...
RAI: 45.52 (+0.11), CAVM: 68.59 (-0.50), LGIH: 29.90 (-0.80), EW: 153.27 (+0.32), RAD: 7.60 (-0.08), YHOO: 32.19 (-1.04), WBA: 79.17 (-1.23), CALM: 54.17 (-1.07), AAPL: 112.34 (-3.38), BABA: 75.85 (-2.91)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading